1H-MRSI can examine spatiotemporal characteristics of metabolic dysfunction in multiple brain regions in early Alzheimer’s disease (AD) pathology. Since both cortical and subcortical gray matter structures have shown vulnerability to AD neurodegeneration, we tested whether regional gray matter metabolic abnormalities were associated with (i) APOE4 genotype, a risk factor for amyloid burden, (ii) CSF p-tau181, an indicator of tau burden, and (iii) morphometry metrics (volume, cortical thickness) indicative of neurodegeneration, in cognitively unimpaired elderly. We found lower caudate Cho and lower posterior cingulate Glx in APOE4 carriers compared to non-carriers. There were no metabolite relationships with CSF p-tau181 or morphometry.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: